|1.||Liu, Shuang: 1 article (09/2008)|
|2.||Fang, Wei: 1 article (09/2008)|
|3.||Liu, Yajing: 1 article (09/2008)|
|4.||Zhu, Lin: 1 article (09/2008)|
|5.||Kim, Young-Seung: 1 article (09/2008)|
|6.||He, Zuo-Xiang: 1 article (09/2008)|
|1.||Coronary Stenosis (Coronary Artery Stenosis)
09/01/2008 - "Evaluation of 99mTcN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis."
09/01/2008 - "In dogs with coronary stenoses, single photon emission computed tomography images were acquired at 30, 60, and 120 min after administration of 99mTcN-15C5 with/without adenosine. "
09/01/2008 - "99mTcN-15C5 and 99mTc-sestamibi had very similar blood clearance characteristics during the first 30 min p.i. The heart/liver ratio of 99mTcN-15C5 increased from 0.48+/-0.05 at 5 min p.i. to 1.85+/-0.11 at 120 min p.i., whereas the heart/liver ratio of 99mTc-sestamibi was improved only slightly from 0.45+/-0.04 at 5 min p.i. to 0.74+/-0.15 at 120 min p.i. SPECT imaging studies in canines with coronary stenoses indicated that good visualization of the perfusion defect could be achieved at 30 min after administration of 99mTcN-15C5 with the adenosine stress. "
|1.||Technetium Tc 99m Sestamibi (Cardiolite)